Resolution of Systemic Hypertension after Laparoscopic Gastric Bypass
Hypertension is a well-recognized and treatable risk factor for coronary heart disease and is one of the most common comorbidities associated with obesity. The aim of this study was to characterize the clinical outcome of a cohort of patients with documented hypertension who underwent laparoscopic gastric bypass.
Ninety-five obese patients with documented hypertension and being treated with antihypertensive medication(s) underwent laparoscopic gastric bypass. Main outcome measures included length of hypertensive condition, changes in systolic and diastolic blood pressures, and changes in antihypertensive medication(s) at follow-up.
There were 69 (72%) females with a mean preoperative body mass index of 47 kg/m2. The mean duration of hypertension was 73 ± 70 months. The mean excess body weight loss at 12 months was 66%. The mean systolic blood pressure significantly decreased from 140 ± 17 mmHg preoperatively to 120 ± 18 mmHg at 12 months (p < 0.01). The mean diastolic blood pressure also significantly decreased from 80 ± 11 mmHg preoperatively to 71 ± 8 mmHg at 12 months (p < 0.01). At 12 months follow-up, 44 (46%) patients had complete resolution of hypertension while 18 (19%) patients had improvement. Patients with complete resolution had a shorter duration of disease as compared to patients without resolution (53 vs. 95 months, respectively, p = 0.01).
Weight loss associated with laparoscopic gastric bypass substantially improves and/or resolves hypertension in the majority of patients. Improvement of hypertension occurs as early as 1 month postoperatively and is more frequently in patients with a shorter preoperative duration of disease.
- Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006;295(13):1549–1555. doi:10.1001/jama.295.13.1549. CrossRef
- Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 2004;291(23):2847–2850. doi:10.1001/jama.291.23.2847. CrossRef
- Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292(14):1724–1737. doi:10.1001/jama.292.14.1724. CrossRef
- Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P, Razak F, Sharma AM, Anand SS. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case–control study. Lancet 2005;366(9497):1640–1649. doi:10.1016/S0140-6736(05)67663-5. CrossRef
- Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999;282(16):1523–1529. doi:10.1001/jama.282.16.1523. CrossRef
- Thomas F, Bean K, Pannier B, Oppert JM, Guize L, Benetos A. Cardiovascular mortality in overweight subjects: The key role of associated risk factors. Hypertension 2005;46(4):654–659. doi:10.1161/01.HYP.0000184282.51550.00. CrossRef
- Nguyen NT, Varela E, Sabio A, Tran CL, Stamos M, Wilson SE. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg 2006;203(1):24–29. doi:10.1016/j.jamcollsurg.2006.03.019. CrossRef
- Nguyen NT, Varela JE, Sabio A, Naim J, Stamos M, Wilson SE. Reduction in prescription medication costs after laparoscopic gastric bypass. Am Surg 2006;72(10):853–856.
- Varela JE, Hinojosa MW, Nguyen NT. Resolution of obstructive sleep apnea after laparoscopic gastric bypass. Obes Surg 2007;17(10):1279–1282. doi:10.1007/s11695-007-9228-6. CrossRef
- Pajecki D, Dalcanalle L, Souza de Oliveira CP, Zilberstein B, Halpern A, Garrido AB, Cecconello I. Follow-up of Roux-en-Y gastric bypass patients at 5 or more years postoperatively. Obes Surg 2007;17(5):601–607. doi:10.1007/s11695-007-9104-4. CrossRef
- Sjostrom CD, Lissner L, Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999;7(5):477–484.
- Yan E, Ko E, Luong V, Wang HJ, Romanova M, Li Z. Long-term changes in weight loss and obesity-related comorbidities after Roux-en-Y gastric bypass: a primary care experience. Am J Surg 2008;195(1):94–98. doi:10.1016/j.amjsurg.2007.01.036. CrossRef
- Batsis JA, Romero-Corral A, Collazo-Clavell ML, Sarr MG, Somers VK, Brekke L, Lopez-Jimenez F. Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery. Obesity (Silver Spring) 2007;15(3):772–784. doi:10.1038/oby.2007.589. CrossRef
- Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005;142(7):547–559.
- Ali MR, Maguire MB, Wolfe BM. Assessment of obesity-related comorbidities: a novel scheme for evaluating bariatric surgical patients. J Am Coll Surg 2006;202(1):70–77. doi:10.1016/j.jamcollsurg.2005.09.014. CrossRef
- Ruano M, Silvestre V, Castro R, Garcia-Lescun MC, Rodriguez A, Marco A, Garcia-Blanch G. Morbid obesity, hypertensive disease and the renin–angiotensin–aldosterone axis. Obes Surg 2005;15(5):670–676. doi:10.1381/0960892053923734. CrossRef
- Sjostrom CD. Surgery as an intervention for obesity. Results from the Swedish Obese Subjects study. Growth Horm IGF Res 2003;13(Suppl A):S22–S26. CrossRef
- Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003;237(6):751–756. discussion 757–758. doi:10.1097/00000658-200306000-00002. CrossRef
- Vogel JA, Franklin BA, Zalesin KC, Trivax JE, Krause KR, Chengelis DL, McCullough PA. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am J Cardiol 2007;99(2):222–226. doi:10.1016/j.amjcard.2006.08.017. CrossRef
- Fernstrom JD, Courcoulas AP, Houck PR, Fernstrom MH. Long-term changes in blood pressure in extremely obese patients who have undergone bariatric surgery. Arch Surg 2006;141(3):276–283. doi:10.1001/archsurg.141.3.276. CrossRef
- Sjostrom CD, Peltonen M, Wedel H, Sjostrom L. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000;36(1):20–25.
- Huerta S, Kohan D, Siddiqui A, Anthony T, Livingston EH. Assessment of comorbid conditions in veteran patients after Roux-en-Y gastric bypass. Am J Surg 2007;194(1):48–52. doi:10.1016/j.amjsurg.2006.11.017. CrossRef
- Campese VM, Mitra N, Sandee D. Hypertension in renal parenchymal disease: why is it so resistant to treatment. Kidney Int 2006;69(6):967–973. doi:10.1038/sj.ki.5000177. CrossRef
- Hall JE. The kidney, hypertension, and obesity. Hypertension 2003;41(3):625–633. doi:10.1161/01.HYP.0000052314.95497.78. CrossRef
- Resolution of Systemic Hypertension after Laparoscopic Gastric Bypass
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
Journal of Gastrointestinal Surgery
Volume 13, Issue 4 , pp 793-797
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Bariatric surgery
- Morbid obesity
- Systemic hypertension
- Gastric bypass
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, University of California, Irvine Medical Center, Orange, CA, USA
- 2. Department of Surgery, University of Texas Southwestern, Dallas, TX, USA
- 3. Division of Gastrointestinal Surgery, University of California, Irvine Medical Center, 333 City Boulevard West, Suite 850, Orange, CA, 92868, USA